Sign in
AXLA Stock Price, Chart, Stats & News
Axcella Health Inc.
Save
12.50M
Market cap
–
Current P/E
–
Forward P/E
AXLA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -428.94% |
ROE | -620.40% |
D/E | 0.52x |
Interest coverage ratio | -24.10x |
AXLA valuation
P/E | – |
P/S | – |
P/B | 70.41x |
P/CF | -4.21x |
P/FCF | -0.18x |
P/OCF | -4.21x |
PEG | -0.04x |
EV multiple | -0.35x |
About
Axcella Health Inc. is a U. S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health.
Similar securities
Based on sector and market capitalization
Report issue